Literature DB >> 12504904

Inhibition of the cysteine proteinases cathepsins K and L by the serpin headpin (SERPINB13): a kinetic analysis.

Arumugam Jayakumar1, Ya'an Kang, Mitchell J Frederick, Stephen C Pak, Ying Henderson, Paula R Holton, Kenji Mitsudo, Gary A Silverman, Adel K EL-Naggar, Dieter Brömme, Gary L Clayman.   

Abstract

Headpin (SERPINB13) is a novel member of the serine proteinase inhibitor (Serpin) gene family that was originally cloned from a keratinocyte cDNA library. Western blot analysis using a headpin-specific antiserum recognized a protein with the predicted M(r) of 44kDa in lysates derived from a transformed keratinocyte cell line known to express headpin mRNA. Similarity of the reactive-site loop (RSL) domain of headpin, notably at the P1-P1(') residues, with other serpins that inhibit cysteine and serine proteinases suggests that headpin may inhibit similar proteinases. This study demonstrates that recombinant headpin indeed inhibits cathepsins K and L, but not chymotrypsin, elastase, trypsin, subtilisin A, urokinase-type plasminogen activator, plasmin, or thrombin. The second-order rate constants (k(a)) for the inhibitory reactions of rHeadpin with cathepsins K and L were 5.1+/-0.6x10(4) and 4.1+/-0.8x10(4)M(-1)s(-1), respectively. Headpin formed SDS-stable complexes with cathepsins K and L, a characteristic property of inhibitory serpins. Interactions of the RSL domain of headpin with cathepsins K and L were indicated by cleavage of headpin near the predicted P1-P1(') residues by these proteinases. These results demonstrate that the serpin headpin possesses specificity for inhibiting lysosomal cysteine proteinases.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12504904     DOI: 10.1016/s0003-9861(02)00635-5

Source DB:  PubMed          Journal:  Arch Biochem Biophys        ISSN: 0003-9861            Impact factor:   4.013


  10 in total

1.  Enhanced anti-serpin antibody activity inhibits autoimmune inflammation in type 1 diabetes.

Authors:  Jan Czyzyk; Octavian Henegariu; Paula Preston-Hurlburt; Raman Baldzizhar; Christine Fedorchuk; Enric Esplugues; Kim Bottomly; Frans K Gorus; Kevan Herold; Richard A Flavell
Journal:  J Immunol       Date:  2012-05-16       Impact factor: 5.422

2.  Multiple domains of endopin 2A for serpin cross-class inhibition of papain.

Authors:  Shin-Rong Hwang; Vivian Y H Hook
Journal:  Arch Biochem Biophys       Date:  2007-03-21       Impact factor: 4.013

3.  SERPINB13 is a novel RUNX1 target gene.

Authors:  Anita Boyapati; Bing Ren; Dong-Er Zhang
Journal:  Biochem Biophys Res Commun       Date:  2011-06-23       Impact factor: 3.575

4.  Cellular proliferation in mouse and human pancreatic islets is regulated by serpin B13 inhibition and downstream targeting of E-cadherin by cathepsin L.

Authors:  Chi-Wen Lo; Yury Kryvalap; Tzong-Jen Sheu; Ching-Ho Chang; Jan Czyzyk
Journal:  Diabetologia       Date:  2019-03-01       Impact factor: 10.122

5.  Human SERPINB12 Is an Abundant Intracellular Serpin Expressed in Most Surface and Glandular Epithelia.

Authors:  Jason Z Niehaus; Misty Good; Laura E Jackson; John A Ozolek; Gary A Silverman; Cliff J Luke
Journal:  J Histochem Cytochem       Date:  2015-07-28       Impact factor: 2.479

6.  Anti-serpin antibody-mediated regulation of proteases in autoimmune diabetes.

Authors:  Raman Baldzizhar; Christine Fedorchuk; Mithilesh Jha; Chozhavendan Rathinam; Octavian Henegariu; Jan Czyzyk
Journal:  J Biol Chem       Date:  2012-11-29       Impact factor: 5.157

7.  Serpin Inhibition Mechanism: A Delicate Balance between Native Metastable State and Polymerization.

Authors:  Mohammad Sazzad Khan; Poonam Singh; Asim Azhar; Asma Naseem; Qudsia Rashid; Mohammad Anaul Kabir; Mohamad Aman Jairajpuri
Journal:  J Amino Acids       Date:  2011-05-24

8.  Lysoptosis is an evolutionarily conserved cell death pathway moderated by intracellular serpins.

Authors:  Cliff J Luke; Stephanie Markovina; Misty Good; Ira E Wight; Brian J Thomas; John M Linneman; Wyatt E Lanik; Olga Koroleva; Maggie R Coffman; Mark T Miedel; Qingqing Gong; Arlise Andress; Marlene Campos Guerrero; Songyan Wang; LiYun Chen; Wandy L Beatty; Kelsey N Hausmann; Frances V White; James A J Fitzpatrick; Anthony Orvedahl; Stephen C Pak; Gary A Silverman
Journal:  Commun Biol       Date:  2022-01-12

9.  Cathepsin K associates with lymph node metastasis and poor prognosis in oral squamous cell carcinoma.

Authors:  Frank K Leusink; Eleftherios Koudounarakis; Michael H Frank; Ronald Koole; Paul J van Diest; Stefan M Willems
Journal:  BMC Cancer       Date:  2018-04-05       Impact factor: 4.430

10.  Stable depletion of RUNX1-ETO in Kasumi-1 cells induces expression and enhanced proteolytic activity of Cathepsin G and Neutrophil Elastase.

Authors:  Caroline Schoenherr; Katharina Wohlan; Iris Dallmann; Andreas Pich; Jan Hegermann; Arnold Ganser; Denise Hilfiker-Kleiner; Olaf Heidenreich; Michaela Scherr; Matthias Eder
Journal:  PLoS One       Date:  2019-12-11       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.